News About: Pharm. Industry
Listed pharmas’ decent external business growth
Listed pharmaceutical companies were evaluated having a decent business performance this year, but sales gaps between the companies were intensified.
1 of 3 listed pharmaceutical companies had a decrease in operating...
Ilyang Pharmaceutical’s ‘Supect’ effectively inhibits Parkinson’s disease progress
The preclinical and efficacy result on the Ilyang Pharmaceutical’s(President Dong-Yeon Kim) chronic myelocytic leukemia treatment ‘Supect(generic name: radotinib)’ for Parkinson’s disease(PD) was announced at the ‘Ame...
23 Korean potential biotech companies will gather in event
The Korea Biotechnology Industry Organization(President Jeong-Sun Seo, KoreaBIO) will hold a biotech pipeline investor forum jointly with Mirae Asset Daewoo for a week from the 13th at the Mirae Asset Daewoo headquart...
Pharmas get huge impacts if being careless on ‘Financial Gain and Expenditure Report’
While the ‘Financial Gain and Expenditure Report’ will be implemented January next year, pharmaceutical companies were criticized to have thorough preparations.
This is because they might get in a huge trouble as jud...
Kwang Dong Pharmaceutical signs contract sales agreement of Jeju Samdasoo
Kwang Dong Pharmaceutical(CEO Sung-Won Choi) announced on the 9th that it signed a contract sales agreement of Jeju Samdasoo retail products with the Jeju Province Development Co.(President Kyung-Soo Oh) at Sheraton S...
Humira takes over ‘uveitis’ as well with versatility
‘Humira(generic name: adalimumab),’ the most well-known TNF(tumor necrosis factor)-α inhibitor and a chronic immune disorder treatment having 14 Korean indications in Korea, has attracted attention of the industry as ...
Samsung Bioepis acquires product approval of ‘Samfenet,’ Herceptin biosimilar
‘SB3(product name: Samfenet, generic name: trastuzumab),’ a Samsung Bioepis’ cancer therapy biosimilar, acquire product approval from the Ministry of Food and Drug Safety on the 8th.
Samfenet is a biosimilar of ‘Herc...
Pharmaceutical companies’ poor quality control on their imported medicines
Multinational pharmaceutical companies were criticized for poorly managing their imported medicines.
According to the Ministry of Food and Drug Safety(MFDS), there has been an increasing number of multinational pharm...
Big5 pharmas, Yuhan and Daewoong top in sales and profitability respectively
While the ‘Big5’ pharmaceutical companies’ business performance is evaluated excellent this year, Yuan Corporation and Daewoong Pharmaceutical was analyzed to have a remarkable business performance.
Yakup Shinmoon(ww...
No. of employees in pharma field was approx. 64 thousand, increased by 4.8% year-on-year
The number of employees in the pharmaceutical field was about 64 thousand increased by 4.8% year-on-year in the 1st half of the year, but it was the lowest increase among other fields in the health care industry.
The...
